Prasugrel
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3311 publications
Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study?
Journal: Journal of atherosclerosis and thrombosis
Published: March 29, 2026
Assessment of and Factors Contributing to Adequate Endothelization After Drug-Eluting Stent Implantation.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 26, 2026
Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial.
Journal: Cardiology in review
Published: March 20, 2026
Contemporary Trends in High-Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Journal: Journal of the American Heart Association
Published: March 18, 2026
Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 18, 2026
P2Y12 Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS Study.
Journal: Journal of atherosclerosis and thrombosis
Published: March 04, 2026
High-performance bioimaging and biosensing via nucleobase-editing enzymes.
Journal: Chemical Society reviews
Published: March 03, 2026
Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: February 11, 2026
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trial.
Journal: American heart journal
Published: January 28, 2026
The performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE prospective pilot study.
Journal: Journal of Yeungnam medical science
Published: January 19, 2026
Retrospective observational analysis of prasugrel dosage afterpercutaneous coronary intervention using the Clinical Deep DataAccumulation System database.
Journal: Global health & medicine
Published: January 09, 2026
Last Updated: 04/28/2026